These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 10719364)
21. Suppression of the tumorigenic phenotype by chromosome 18 transfer into pancreatic cancer cell lines. Lefter LP; Furukawa T; Sunamura M; Duda DG; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A Genes Chromosomes Cancer; 2002 Jun; 34(2):234-42. PubMed ID: 11979557 [TBL] [Abstract][Full Text] [Related]
22. Analysis of human meningiomas for aberrations of the MADH2, MADH4, APM-1 and DCC tumor suppressor genes on the long arm of chromosome 18. Büschges R; Boström J; Wolter M; Blaschke B; Weber RG; Lichter P; Collins VP; Reifenberger G Int J Cancer; 2001 May; 92(4):551-4. PubMed ID: 11304690 [TBL] [Abstract][Full Text] [Related]
23. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Höhne MW; Halatsch ME; Kahl GF; Weinel RJ Cancer Res; 1992 May; 52(9):2616-9. PubMed ID: 1314700 [TBL] [Abstract][Full Text] [Related]
24. Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients. Koyama M; Ito M; Nagai H; Emi M; Moriyama Y Mutat Res; 1999 Aug; 406(2-4):71-7. PubMed ID: 10479724 [TBL] [Abstract][Full Text] [Related]
25. DCC genetic alterations and expression in endometrial carcinoma. Ronnett BM; Burks RT; Cho KR; Hedrick L Mod Pathol; 1997 Jan; 10(1):38-46. PubMed ID: 9021725 [TBL] [Abstract][Full Text] [Related]
26. Exclusion of Madh2, Madh4, and Madh7 as candidates for the modifier of Min 2 (Mom2) locus. Silverman KA; Koratkar RA; Siracusa LD; Buchberg AM Mamm Genome; 2003 Feb; 14(2):119-29. PubMed ID: 12584607 [TBL] [Abstract][Full Text] [Related]
27. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors. Hessman O; Lindberg D; Einarsson A; Lillhager P; Carling T; Grimelius L; Eriksson B; Akerström G; Westin G; Skogseid B Genes Chromosomes Cancer; 1999 Nov; 26(3):258-64. PubMed ID: 10502325 [TBL] [Abstract][Full Text] [Related]
28. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition. Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332 [TBL] [Abstract][Full Text] [Related]
29. Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis. Inoue H; Furukawa T; Sunamura M; Takeda K; Matsuno S; Horii A Genes Chromosomes Cancer; 2001 Jul; 31(3):295-9. PubMed ID: 11391801 [TBL] [Abstract][Full Text] [Related]
30. Inactivation of Smad4 in gastric carcinomas. Powell SM; Harper JC; Hamilton SR; Robinson CR; Cummings OW Cancer Res; 1997 Oct; 57(19):4221-4. PubMed ID: 9331080 [TBL] [Abstract][Full Text] [Related]
31. Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene. Bläker H; von Herbay A; Penzel R; Gross S; Otto HF Oncogene; 2002 Jan; 21(1):158-64. PubMed ID: 11791187 [TBL] [Abstract][Full Text] [Related]
32. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells. Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655 [TBL] [Abstract][Full Text] [Related]
33. Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells. Duda DG; Sunamura M; Lefter LP; Furukawa T; Yokoyama T; Yatsuoka T; Abe T; Inoue H; Motoi F; Egawa S; Matsuno S; Horii A Oncogene; 2003 Oct; 22(44):6857-64. PubMed ID: 14534532 [TBL] [Abstract][Full Text] [Related]
34. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Nagatake M; Takagi Y; Osada H; Uchida K; Mitsudomi T; Saji S; Shimokata K; Takahashi T; Takahashi T Cancer Res; 1996 Jun; 56(12):2718-20. PubMed ID: 8665501 [TBL] [Abstract][Full Text] [Related]
35. Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors. Bartsch D; Hahn SA; Danichevski KD; Ramaswamy A; Bastian D; Galehdari H; Barth P; Schmiegel W; Simon B; Rothmund M Oncogene; 1999 Apr; 18(14):2367-71. PubMed ID: 10327057 [TBL] [Abstract][Full Text] [Related]
36. [Alterations in DPC4 gene in pancreatic cancers]. Gu L; Chen J; Cui Q Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):293-5. PubMed ID: 11783110 [TBL] [Abstract][Full Text] [Related]
37. DPC4 gene in various tumor types. Schutte M; Hruban RH; Hedrick L; Cho KR; Nadasdy GM; Weinstein CL; Bova GS; Isaacs WB; Cairns P; Nawroz H; Sidransky D; Casero RA; Meltzer PS; Hahn SA; Kern SE Cancer Res; 1996 Jun; 56(11):2527-30. PubMed ID: 8653691 [TBL] [Abstract][Full Text] [Related]
38. Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma. Takebayashi S; Ogawa T; Jung KY; Muallem A; Mineta H; Fisher SG; Grenman R; Carey TE Cancer Res; 2000 Jul; 60(13):3397-403. PubMed ID: 10910046 [TBL] [Abstract][Full Text] [Related]
39. SMAD4 as a prognostic marker in colorectal cancer. Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640 [TBL] [Abstract][Full Text] [Related]
40. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Hahn SA; Schutte M; Hoque AT; Moskaluk CA; da Costa LT; Rozenblum E; Weinstein CL; Fischer A; Yeo CJ; Hruban RH; Kern SE Science; 1996 Jan; 271(5247):350-3. PubMed ID: 8553070 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]